Hematologic Malignancy
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome
CI-CAN-00001675Explore in graph →
Hematologic19 active trials
- NCIt
- C4037
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001675Explore in graph →
Clinical trials
72 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (15)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03602898 | Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation | withdrawn | Phase 2 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT01652014 | Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies | withdrawn | Phase 2 | 0 | University of Medicine and Dentistry of New JerseyOTHER | 1 |
| Jul 14, 2016 |
| clinicaltrials |
Data updated 22 days agoSource updated Jun 30, 2021source: clinicaltrials